It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Neurons rely heavily on high mitochondrial metabolism to provide sufficient energy for proper development. However, it remains unclear how neurons maintain high oxidative phosphorylation (OXPHOS) during development. Mitophagy plays a pivotal role in maintaining mitochondrial quality and quantity. We herein describe that G protein-coupled receptor 50 (GPR50) is a novel mitophagy receptor, which harbors the LC3-interacting region (LIR) and is required in mitophagy under stress conditions. Although it does not localize in mitochondria under normal culturing conditions, GPR50 is recruited to the depolarized mitochondrial membrane upon mitophagy stress, which marks the mitochondrial portion and recruits the assembling autophagosomes, eventually facilitating the mitochondrial fragments to be engulfed by the autophagosomes. Mutations Δ502-505 and T532A attenuate GPR50-mediated mitophagy by disrupting the binding of GPR50 to LC3 and the mitochondrial recruitment of GPR50. Deficiency of GPR50 causes the accumulation of damaged mitochondria and disrupts OXPHOS, resulting in insufficient ATP production and excessive ROS generation, eventually impairing neuronal development. GPR50-deficient mice exhibit impaired social recognition, which is rescued by prenatal treatment with mitoQ, a mitochondrially antioxidant. The present study identifies GPR50 as a novel mitophagy receptor that is required to maintain mitochondrial OXPHOS in developing neurons.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Zhu, Chao 2 ; Peng, Xuan 3 ; Shi, Zi-Ling 2 ; Lan, Li-Jun 2 ; Ji, Wen-Li 2 ; Luo, Li 4 ; Feng, Lei 5 ; Zhang, Zeng-Li 6 ; Xu, De-en 7 ; Li, Shao 8 ; Qin, Zheng-Hong 9 ; Sun, Yan-Yun 2 ; Schachner, Melitta 10
; Ma, Quan-Hong 2
1 the Second Affiliated Hospital of Soochow University, Department of Neurology and Clinical Research Center of Neurological Disease, Suzhou, China (GRID:grid.452666.5) (ISNI:0000 0004 1762 8363); Soochow University, Institute of Neuroscience & Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-psycho-Diseases, Suzhou, China (GRID:grid.445078.a) (ISNI:0000 0001 2290 4690); College of Basic Medical Sciences, Liaoning Provincial Key Laboratory of Cerebral Diseases, National-Local Joint Engineering Research Center for Drug-Research and Development (R & D) of Neurodegenerative Diseases, Department of Physiology, Dalian, China (GRID:grid.411971.b) (ISNI:0000 0000 9558 1426)
2 the Second Affiliated Hospital of Soochow University, Department of Neurology and Clinical Research Center of Neurological Disease, Suzhou, China (GRID:grid.452666.5) (ISNI:0000 0004 1762 8363); Soochow University, Institute of Neuroscience & Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-psycho-Diseases, Suzhou, China (GRID:grid.445078.a) (ISNI:0000 0001 2290 4690)
3 the Second Affiliated Hospital of Soochow University, Department of Neurology and Clinical Research Center of Neurological Disease, Suzhou, China (GRID:grid.452666.5) (ISNI:0000 0004 1762 8363); Soochow University, Institute of Neuroscience & Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-psycho-Diseases, Suzhou, China (GRID:grid.445078.a) (ISNI:0000 0001 2290 4690); Soochow University, School of Public Health, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694)
4 Soochow University, School of Physical Education and Sports Science, Suzhou, China (GRID:grid.445078.a) (ISNI:0000 0001 2290 4690)
5 Monash Suzhou Research Institute, Suzhou, China (GRID:grid.452673.1)
6 Soochow University, School of Public Health, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694)
7 The Wuxi No.2 People Hospital, Wuxi, China (GRID:grid.440298.3) (ISNI:0000 0004 9338 3580)
8 College of Basic Medical Sciences, Liaoning Provincial Key Laboratory of Cerebral Diseases, National-Local Joint Engineering Research Center for Drug-Research and Development (R & D) of Neurodegenerative Diseases, Department of Physiology, Dalian, China (GRID:grid.411971.b) (ISNI:0000 0000 9558 1426)
9 Suzhou Gaobo Vocational College, Suzhou High-Technology District, Science & Technology Town, 5 Qingshan Road, Institute of Health Technology, Suzhou, PR China (GRID:grid.411971.b)
10 Shantou University Medical College, Shantou, Center for Neuroscience, Guangdong, China (GRID:grid.411679.c) (ISNI:0000 0004 0605 3373); Rutgers University, Keck Center for Collaborative Neuroscience and Department of Cell Biology and Neuroscience, Piscataway, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796)




